These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9176830)

  • 21. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
    Allaire J; Couture P; Leclerc M; Charest A; Marin J; Lépine MC; Talbot D; Tchernof A; Lamarche B
    Am J Clin Nutr; 2016 Aug; 104(2):280-7. PubMed ID: 27281302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia.
    Bunea R; El Farrah K; Deutsch L
    Altern Med Rev; 2004 Dec; 9(4):420-8. PubMed ID: 15656713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
    Goyens PL; Mensink RP
    Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.
    Kelley DS; Siegel D; Vemuri M; Mackey BE
    Am J Clin Nutr; 2007 Aug; 86(2):324-33. PubMed ID: 17684201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
    Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses.
    Calabresi L; Donati D; Pazzucconi F; Sirtori CR; Franceschini G
    Atherosclerosis; 2000 Feb; 148(2):387-96. PubMed ID: 10657575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia.
    Calabresi L; Villa B; Canavesi M; Sirtori CR; James RW; Bernini F; Franceschini G
    Metabolism; 2004 Feb; 53(2):153-8. PubMed ID: 14767865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides.
    Schwellenbach LJ; Olson KL; McConnell KJ; Stolcpart RS; Nash JD; Merenich JA;
    J Am Coll Nutr; 2006 Dec; 25(6):480-5. PubMed ID: 17229894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses.
    Jacobs DM; Mihaleva VV; van Schalkwijk DB; de Graaf AA; Vervoort J; van Dorsten FA; Ras RT; Demonty I; Trautwein EA; van Duynhoven J
    Mol Nutr Food Res; 2015 Sep; 59(9):1745-57. PubMed ID: 26019023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans.
    Rambjør GS; Wålen AI; Windsor SL; Harris WS
    Lipids; 1996 Mar; 31 Suppl():S45-9. PubMed ID: 8729093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid responses in mildly hypertriglyceridemic men and women to consumption of docosahexaenoic acid-enriched eggs.
    Maki KC; Van Elswyk ME; McCarthy D; Seeley MA; Veith PE; Hess SP; Ingram KA; Halvorson JJ; Calaguas EM; Davidson MH
    Int J Vitam Nutr Res; 2003 Oct; 73(5):357-68. PubMed ID: 14639800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial.
    Geppert J; Kraft V; Demmelmair H; Koletzko B
    Br J Nutr; 2006 Apr; 95(4):779-86. PubMed ID: 16571158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
    Asztalos IB; Gleason JA; Sever S; Gedik R; Asztalos BF; Horvath KV; Dansinger ML; Lamon-Fava S; Schaefer EJ
    Metabolism; 2016 Nov; 65(11):1636-1645. PubMed ID: 27733252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the serum TAG response to high-dose supplementation of either DHA or EPA among individuals with increased cardiovascular risk: the ComparED study.
    Allaire J; Vors C; Harris WS; Jackson KH; Tchernof A; Couture P; Lamarche B
    Br J Nutr; 2019 Jun; 121(11):1223-1234. PubMed ID: 30854986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
    Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
    Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
    Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
    Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
    Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
    Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.
    Krokan HE; Bjerve KS; Mørk E
    Biochim Biophys Acta; 1993 May; 1168(1):59-67. PubMed ID: 8504143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.